[144] EXACT SCIENCES CORP SEC Filing

Rhea-AI Filing Summary

Exact Sciences (EXAS) reported a proposed sale of 1,500 common shares by an insider through Fidelity Brokerage Services with an aggregate market value of $90,000. The shares represent a small fraction of the company's outstanding common stock of 189,319,110 shares. The filer acquired these shares on 02/23/2022 through restricted stock vesting and the transaction is classified as compensation. The planned sale date is 10/09/2025 on NASDAQ. No other sales by the filer in the past three months were reported, and the filer certifies they are not aware of undisclosed material adverse information at the time of the notice.

Positive

• Securities were acquired via restricted stock vesting, indicating the sale is monetization of compensation rather than a new short position
• No other sales in the past three months were reported for the filer, suggesting limited recent insider sell activity

Negative

• Insider plans to sell 1,500 shares on 10/09/2025, which may be perceived negatively by some investors despite small size

Insights

Insider Transactions Analyst

Small insider sale tied to vested restricted stock; limited market impact.

The notice shows an insider plans to sell 1,500 shares acquired on 02/23/2022 via restricted stock vesting, valued at $90,000. Because these shares were compensation, the sale appears to be routine monetization of vested equity rather than a position change tied to new information.

The sale represents roughly 0.00079% of the reported 189,319,110 shares outstanding, so direct dilution or price pressure is expected to be negligible. Watch the actual trade execution on 10/09/2025 for timing concentration or multiple related filings that could indicate larger insider activity within the same window.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1500	90000.00	189319110	10/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2022	Restricted Stock Vesting	Issuer			1500	02/23/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider sale did Exact Sciences (EXAS) report in this Form 144?

The filer reported a proposed sale of 1,500 common shares valued at $90,000, planned for 10/09/2025 on NASDAQ.

How were the shares being sold by the insider acquired?

The shares were acquired on 02/23/2022 through restricted stock vesting and were classified as compensation.

How material is this sale relative to Exact Sciences' outstanding shares?

The sale represents about 0.00079% of the stated 189,319,110 outstanding shares, which is immaterial to overall share count.

Did the filer report any other securities sold in the past three months?

No; the filing states "Nothing to Report" for securities sold during the past three months by the filer.

Who is the broker handling the sale?

The broker listed is Fidelity Brokerage Services LLC, with address shown in the notice.